192 related articles for article (PubMed ID: 36275701)
1. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19.
Huang Y; Yuan Y; Chen S; Xu D; Xiao L; Wang X; Qin W; Liu B
Front Immunol; 2022; 13():985781. PubMed ID: 36275701
[TBL] [Abstract][Full Text] [Related]
2. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.
Li R; Li Y; Liang X; Yang L; Su M; Lai KP
Brief Bioinform; 2021 Mar; 22(2):1279-1290. PubMed ID: 33169132
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Liang X; Zhou R; Li Y; Yang L; Su M; Lai KP
Aging (Albany NY); 2021 Jun; 13(12):15785-15800. PubMed ID: 34176789
[TBL] [Abstract][Full Text] [Related]
5. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
Wang L; Ding Y; Zhang C; Chen R
PLoS One; 2022; 17(5):e0269249. PubMed ID: 35639708
[TBL] [Abstract][Full Text] [Related]
6. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
7. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
8. Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.
Singh S; Singh CM; Ranjan A; Kumar S; Singh DK
Indian J Pharmacol; 2021; 53(5):394-402. PubMed ID: 34854410
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and K signaling pathways in hepatocellular carcinoma.
Louka ML; Fawzy AM; Naiem AM; Elseknedy MF; Abdelhalim AE; Abdelghany MA
Gene; 2017 Sep; 629():108-116. PubMed ID: 28764978
[TBL] [Abstract][Full Text] [Related]
10. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
Front Immunol; 2021; 12():769011. PubMed ID: 35069542
[TBL] [Abstract][Full Text] [Related]
11. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
12. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
13. The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells.
Shi L; Zheng X; Fan Y; Yang X; Li A; Qian J
BMC Gastroenterol; 2019 Jul; 19(1):130. PubMed ID: 31340754
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets.
Wang S; Gao H; Wang X; Ma X; Zhang L; Xing Y; Jia Y; Wang Y
Front Pharmacol; 2022; 13():874637. PubMed ID: 35571107
[No Abstract] [Full Text] [Related]
15. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets.
Luo H; Chen J; Jiang Q; Yu Y; Yang M; Luo Y; Wang X
Clin Epigenetics; 2023 Jun; 15(1):100. PubMed ID: 37309005
[TBL] [Abstract][Full Text] [Related]
17. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
[TBL] [Abstract][Full Text] [Related]
18. Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin.
Li Y; Yu S; Li Y; Liang X; Su M; Li R
Front Endocrinol (Lausanne); 2021; 12():714909. PubMed ID: 34712201
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
20. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
